PM
49
-7
FFIV
62
-4
AIZ
42
-10
GWW
39
-5
XEL
36
-14
NWS
62
-2
CMCSA
35
8
GS
59
-7
DVN
35
13
HP
56
4
DD
36
-2
PSA
38
-3
WHR
68
6
JPM
50
-5
CMG
54
-3
PCAR
42
-3
NWSA
58
-2
MKC
47
-6
CFG
40
-12
LB
69
5
PM
49
-7
FFIV
62
-4
AIZ
42
-10
GWW
39
-5
XEL
36
-14
NWS
62
-2
CMCSA
35
8
GS
59
-7
DVN
35
13
HP
56
4
DD
36
-2
PSA
38
-3
WHR
68
6
JPM
50
-5
CMG
54
-3
PCAR
42
-3
NWSA
58
-2
MKC
47
-6
CFG
40
-12
LB
69
5
Financhill
Back

ProShares UltraShort Dow30 Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
46

DXD
ProShares UltraShort Dow30

Last Price:
$27.83
Seasonality Move:
-5.63%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
46
ProShares UltraShort Dow30 (DXD) is a Sell

Is ProShares UltraShort Dow30 a Buy, Sell or Hold?

  • The current ProShares UltraShort Dow30 [DXD] share price is $27.83. The Score for DXD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DXD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DXD Stock Price Chart

What is ProShares UltraShort Dow30's stock price today?

  • The ProShares UltraShort Dow30 share price today is $27.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXD is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

DXD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 65.21 Buy
Chaikin Money Flow: 534024 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.23 - 27.21) Buy
Bollinger Bands (100): (25.69 - 28.75) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

DXD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.06 Buy
20-day SMA: 26.58 Buy
50-day SMA: 26.17 Buy
200-day SMA: 29.62 Sell
8-day EMA: 27.06 Buy
20-day EMA: 26.63 Buy
50-day EMA: 26.54 Buy
200-day EMA: 29.46 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

ProShares UltraShort Dow30 Earnings Growth & DXD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

ProShares UltraShort Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):